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Introduction: A major determinant of the potential size of cell/scaffold constructs in tissue engineering is
vascularization. The aims of this study were twofold: first to determine the in vitro angiogenic and osteogenic gene-
expression profiles of endothelial cells (ECs) and mesenchymal stem cells (MSCs) cocultured in a dynamic 3D
environment; and second, to assess differentiation and the potential for osteogenesis after in vivo implantation.
Methods: MSCs and ECs were grown in dynamic culture in poly(L-lactide-co-1,5-dioxepan-2-one) (poly(LLA-co-DXO))
copolymer scaffolds for 1 week, to generate three-dimensional endothelial microvascular networks. The constructs were
then implanted in vivo, in a murine model for ectopic bone formation. Expression of selected genes for angiogenesis
and osteogenesis was studied after a 1-week culture in vitro. Human cell proliferation was assessed as expression of ki67,
whereas α-smooth muscle actin was used to determine the perivascular differentiation of MSCs. Osteogenesis was
evaluated in vivo through detection of selected markers, by using real-time RT-PCR, alkaline phosphatase (ALP), Alizarin
Red, hematoxylin/eosin (HE), and Masson trichrome staining.
Results: The results show that endothelial microvascular networks could be generated in a poly(LLA-co-DXO) scaffold
in vitro and sustained after in vivo implantation. The addition of ECs to MSCs influenced both angiogenic and
osteogenic gene-expression profiles. Furthermore, human ki67 was upregulated before and after implantation. MSCs
could support functional blood vessels as perivascular cells independent of implanted ECs. In addition, the expression
of ALP was upregulated in the presence of endothelial microvascular networks.
Conclusions: This study demonstrates that copolymer poly(LLA-co-DXO) scaffolds can be prevascularized with ECs
and MSCs. Although a local osteoinductive environment is required to achieve ectopic bone formation, seeding of
MSCs with or without ECs increases the osteogenic potential of tissue-engineered constructs.
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In tissue engineering, the reconstruction of bone defects
by using stem cells seeded onto biodegradable carrier
materials requires timely formation of functional blood
vessels. After in vivo implantation, complex tissues are
dependent on a functional vasculature, not only for cell
survival, but also for tissue organization. In several* Correspondence: torbjorn.pedersen@iko.uib.no
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reproduction in any medium, provided the orrecent review articles, vascularization was highlighted as
a major determinant of the potential size of cell/scaffold
constructs [1-3]. The osteogenic potential of bone mar-
row was demonstrated by Friedenstein et al. [4] many
years ago. It is suggested that mesenchymal stem cells
(MSCs) derived from bone marrow differentiate prefer-
entially along the osteogenic lineage [5]. It is well
documented that MSCs can differentiate into skeletal
cell types, such as osteoblasts (OBs), chondrocytes, adi-
pocytes, and fibroblasts. Various reports have also found
that MSCs possess greater differentiation potential,al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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For review, see [6].
The establishment of a biological vasculature within a
tissue-engineered construct influences differentiation of
cells present and, subsequently, development of the
tissue [7]. In the process of bone formation, vascular
endothelial cells (ECs) are intimately associated with
osteogenic cells, and ECs are regarded as important reg-
ulators of osteogenic differentiation [8,9]. The addition
of ECs to osteogenic cells has been shown to cause in-
creased bone formation in calvarial defects as well as after
subcutaneous implantation [8,10]. Prevascularization, in
which three-dimensional EC microvascular networks are
developed in vitro through coculture of ECs and MSCs
before in vivo implantation, is therefore an approach
whereby the phenotype of MSCs delivered to tissue de-
fects might be altered.
The osteoinductive properties of scaffold materials are
also important in optimizing constructs for cell-based
tissue regeneration. Several authors have shown that
various scaffolding materials, including polymer, can in-
duce ectopic bone formation [8,11,12]. In vitro findings
have also suggested that poly(LLA-co-DXO) scaffolds
enhance differentiation of osteogenic cells [13].
In the present study, ECs and MSCs were cocultured
onto three-dimensional copolymer scaffolds. The aim
was to investigate how the creation of microvascular
networks affect the angiogenic and osteogenic gene-
expression profiles. A murine model for ectopic bone
formation was used to assess further the cellular differ-
entiation and the potential for osteogenesis after in vivo
implantation.
Methods
Cell culture
Human umbilical vein endothelial cells (ECs) were
purchased from Lonza (Clonetics, Walkersville, MD,
USA). According to the manufacturer’s instructions, ECs
were expanded in Endothelial Cell Growth Medium
(EGM) (Lonza) containing 500 ml Endothelial Cell Basal
Medium and supplements: FBS, 10 ml; BBE, 2 ml; hEGF,
0.5 ml; hydrocortisone, 0.5 ml; and GA-1000, 0.5 ml.
From StemCell Technologies (Vancouver, BC, Canada)
primary human bone marrow-derived stem cells (MSCs)
were purchased, and expanded in MesenCult complete
medium (StemCell Technologies). Flow cytometry was
performed to investigate the purity of the cells; it was
found that >90% of the cells expressed CD29, CD44,
CD105, and CD166, whereas <1% expressed CD14,
CD34, and CD45. Cells no older than passage five were
used, and all cells were cultured at 37°C and 5% CO2.
To simplify imaging, retroviral transfection of ECs at an
early passage with green fluorescent protein (GFP) was
performed [14]. Pulmonary artery smooth muscle cells(SMCs) were purchased from Lonza and expanded in
Smooth Muscle Growth Medium-2 (SmGM-2) (Lonza),
according to the manufacturer’s instructions. MSCs and
SMCs grown in vitro were stained with mouse anti-
human α-smooth muscle actin (α-SMA) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) incubated in a
1:200 dilution for 4 hours at room temperature with
Alexa594-conjugated goat anti-mouse IgG as secondary
antibody diluted 1:3,000 for 2 hours.Preparation of cell-seeded scaffolds
Fabrication of poly(LLA-co-DXO) scaffolds was described
thoroughly in previous publications [15,16], and scaffolds
seeded with cells for in vivo implantation were prepared
in a similar way to the one described by Xing et al. [10].
In brief, the scaffolds were prewet with MesenCult
complete medium (StemCell Technologies) and incubated
overnight at 37°C and in 5% CO2. Then, 5 × 10
5 cells were
seeded per scaffold, either MSCs alone or MSCs/ECs in a
5:1 ratio. To facilitate distribution of cells, an orbital
shaker (Eppendorf, Germany) was used, and cells were
allowed to attach overnight before scaffolds were trans-
ferred to separate modified spinner flasks (Wheaton
Science, Millville, NJ, USA) for 1 week in a dynamic cul-
ture system with 50 rotations per minute. MesenCult
complete medium without angiogenic or osteogenic sup-
plements was used for both experimental groups. At 1
week, 6-mm discs were punctured from the scaffolds by
using a dermal skin puncher and either processed for
in vitro analysis or implanted in vivo.Surgical procedures
All animal experiments were approved by the Norwegian
Animal Research Authority and conducted according to
the European Convention for the Protection of Verte-
brates used for Scientific Purposes, with local approval
numbers 3029 and 1572. For subcutaneous implantation,
16 nonobese severe combined immunodeficient (NOD/
SCID) mice (Gade Institute/Taconic Farms) were used.
Animals were aged 6 to 8 weeks at the time of the oper-
ation. An intramuscular injection of 20 μl of Rompun
(xylazine) (20 mg/ml) (Bayer Health Care, Leverkusen,
Germany) and Narketan (ketamine) (Vétoquinol, Lure,
France) in a 1:2 ratio was given to anesthetize the
animals. On the backs of the mice, a 2.5-cm incision
was made, providing sufficient space for subcutaneous
implantation of scaffolds. Wounds were closed with
Vetbond Tissue Adhesive (n-butyl cyanoacrylate) (3M,
St. Paul, MN, USA). Animals were euthanized with
deep isoflurane (Schering Plough, Kenilworth, NJ,
USA) anesthesia and subsequent cervical dislocation at
1 and 3 weeks. Scaffolds were given careful biopsies
and fixated.
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operated on in a model described previously [10]. In
brief, cell/scaffold constructs were implanted into 6-mm
calvarial bone defects, and the animals were euthanized
and samples retrieved after 8 weeks.
Real-time RT-PCR
RNA was extracted by using an E.Z.N.A. Total RNA Kit
(Omega Bio-Tek, Norcross, GA, USA). Quantification
and determination of RNA purity was performed with a
Nanodrop Spectrophotometer (ThermoScientific Nano-
Drop Technologies, Wilmington, DE, USA). A high-
capacity cDNA Archive Kit (Applied Biosystems, Carlsbad,
CA, USA) was used for the reverse-transcription reaction.
Total RNA (1,000 ng) was mixed with nuclease-free water,
reverse transcriptase buffer, random primers, dNTP, and
MultiScribe reverse transcriptase. Real-time RT-PCR was
performed on a StepOne real-time PCR system (Applied
Biosystems). Standard enzyme and cycling conditions were
used, with cDNA corresponding to 10 ng mRNA in each
reaction, prepared in duplicates for each target gene.
Taqman gene-expression assays were human ki67, human
and mouse CD31, human and mouse vascular endothelial
growth factor (VEGF), human and mouse α-SMA,
mouse alkaline phosphatase (ALP), mouse osteopontin
(OP), and mouse collagen I (COL I). Data analysis was
performed with a comparative Ct method with GAPDH
as endogenous control.
For superarray analysis of angiogenesis and osteogen-
esis, Rt2 Profiler PCR Arrays (SuperArray Bioscience,
Frederick, MD, USA) were used. Rt2 PCR array First
Strand Kit (SuperArray Bioscience) was used for cDNA
synthesis, and PCR was performed on a StepOne real-
time PCR system (Applied Biosystems), with Rt2 Real-
time SyBR Green/Rox PCR mix (SuperArray Bioscience).
Histologic evaluation
Samples intended for cryosectioning were immediately fro-
zen in O.C.T. tissue-tech (Sakura Finetek, Tokyo, Japan),
by using 2-methylbutan ReagentPlus (Sigma-Aldrich, St.
Louis, MO, USA) and liquid nitrogen. Cryosectioning was
performed on a Leica CM 3050S (Leica Microsystems,
Wetzlar, Germany) at −24°C into 8-μm sections. Samples
intended for paraffin sectioning were fixated in 4% PFA be-
fore embedding. Sections acquired from the middle parts
of the samples were stained with CD31 mouse anti-human
primary antibody (BD Biosciences, San Jose, CA, USA) or
vimentin mouse anti-human primary antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) diluted 1:200 in PBS
with 5% goat serum. FITC-conjugated goat anti-mouse
(Invitrogen) was used as secondary antibody (1:1,000).
DAPI was used for nuclear staining (1:3,000) for 2 minutes
at room temperature. Double staining with TRITC-
conjugated Ulex europaeus Agglutinin (UEA-1) and CD31was performed to evaluate the interaction between im-
planted human vessels and the host circulation. All vessels
were stained with UEA-1 (Sigma-Aldrich) (diluted 1:500)
by incubation for 2 hours at room temperature protected
from light. Human vessels were stained as previously de-
scribed. Scaffolds were autofluorescent with DAPI filter.
Staining for α-SMA was done on 5-μm sections of
formalin-fixed and paraffin-embedded scaffolds. The
sections were deparaffinized with xylene and rehydrated
in decreasing concentrations of ethanol to water. Pre-
treatment of the sections was done by using antigen re-
trieval at 57°C overnight in Target Retrieval Solution, pH
6.0 (Dako, Glostrup, Denmark) after 8-minute incuba-
tion with Dual Endogenous Enzyme-Blocking Reagent
(Dako). Sections were incubated for 30 minutes at room
temperature with monoclonal mouse anti-human α-SMA
(M0851; Dako) diluted 1:200. Rat-anti-Mouse-IgG2a/AP
secondary antibody was used, and α-SMA visualized by
incubating with the Ferangi Blue Chromogen Kit (Biocare
Medical, Concord, CA, USA) for 20 minutes at room
temperature. Antibody specificity was validated by using
negative-control sections containing mouse vascular tis-
sue and positive-control sections containing human vas-
cular tissue.
Alkaline phosphatase staining was performed with
freshly made substrate solution (Sigma-Aldrich) containing
100 mM Tris-maleate buffer, 8 mg/ml Naphthol AS-TR,
and 2 mg/ml Diazoniumsalt Fast Red Violet LB. Slides
were incubated for 2 hours at room temperature, before
washing with distilled water and counterstaining with 0.1%
fast green. Alizarin Red staining was performed with 2%
Alizarin Red powder (Sigma-Aldrich) dissolved in distilled
water, with pH adjusted to 4.2 with 0.5% ammonium hy-
droxide for 20 minutes at room temperature. A graded al-
cohol and xylol series was applied before mounting with
eukitt (O. Kindler, Freiburg, Germany). Alizarin Red stain-
ing was quantified from three sections at 10× magnifica-
tion for each sample, covering the area of the sections. The
total sample size was four mice for each group. A common
threshold was applied to all images, identifying high-
density areas of red staining by using NIS-Elements BR
3.07 (Nikon, Tokyo, Japan) with a resulting quantified total
area fraction of calcified nodules. Masson trichrome and
HE staining was performed on in vivo samples.
A Nikon 80i microscope (Nikon) was used for light
microscopy, and confocal images were acquired on a
Zeiss LSM 510 Meta (Carl Zeiss, Oberkocken, Germany).
All sections stained with fluorescent secondary antibodies
were mounted with Prolong Gold Antifade Reagent
(Invitrogen) before imaging.
Statistical analysis
PCR data presented are from six parallel samples.
Groups with monocultured MSCs or MSCs/ECs were
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P < 0.05 was defined as a significant difference. SPSS
Statistics 19.0 (IBM, Armonk, NY, USA) was applied for
statistical processing and analysis.
Results
In EC/MSC constructs, endothelial microvascular net-
works were observed after 1 week of dynamic culture
in vitro (Figure 1A, left). Moreover, 1 week after in vivo
implantation, ECs positive for human CD31 were orga-
nized into networks (Figure 1A, middle) and tubular
structures (Figure 1A, right). In monocultured MSCs, no
human endothelial microvascular structures were detected
(not shown). Incorporation of implanted human ECs with
the surrounding vascular bed was observed through
double staining for human and mouse blood vessels
(Figure 1B). As expected, gene-expression levels of human
CD31 were higher in cocultured constructs at 1 and 3
weeks of implantation and did not subside during the ex-
perimental period (Figure 1C).
Gene-expression profiles were evaluated after 1 week
of dynamic culture, before the cell/scaffold constructsFigure 1 Development of endothelial cell (EC) microvascular network
expressing ECs organized in a microvascular network after 1 week of dynam
micrograph of ECs stained with human CD31 (green) organized in network
bar = 20 μm. Right: Confocal micrograph of tubular CD31+ human EC at 1
were incorporated with surrounding UEA-1+ ECs from the mouse circulatio
(40×). Scale bar = 20 μm. (C) The relative expression of human CD31 was h
expression of human CD31 increased between 1 and 3 weeks. *P < 0.05; nwere implanted in vivo. Evaluation of genes related to
angiogenesis showed that in all, 37 genes were down-
regulated, and six genes were upregulated, with a fold
change more than three in the MSC/EC group, compared
with monocultured MSCs (Figure 2A). Functional group-
ing showed that genes related to skeletal development and
the extracellular matrix (ECM), were expressed predomin-
antly in monocultured MSCs, whereas higher expression
of genes was found related to cell growth and differenti-
ation in cocultures (Table 1). The mRNA expression of
VEGF of mouse origin was higher in monocultured con-
structs at 1 week, although not statistically significantly. At
3 weeks, the expression was similar for both experimental
groups (Figure 2B). VEGF from the implanted human cells
showed the opposite tendency, with upregulation in
cocultured constructs at 3 weeks (Figure 2C). However,
when we analyzed the expression of mouse CD31, only
minor differences were found during the experimental
period, suggesting a similar effect from both constructs on
the ingrowth of host ECs (Figure 2D).
Perivascular α-SMA was used as a biomarker to assess
maturation of developing mouse vasculature into thes in a 3D copolymer scaffold. (A) Left: Light micrograph of GFP-
ic culture in vitro (20×). Scale bar = 50 μm. Middle: Confocal
s at 1 week in vivo (40×). Nuclei were stained with DAPI (blue). Scale
week in vivo (60×). Scale bar = 10 μm. (B) Human CD31-positive cells
n after 1 week of implantation, as demonstrated by double staining
igher in MSC/EC constructs after 1 week of implantation, and the
= 6.
Figure 2 Angiogenic signaling from mono- and cocultured constructs and the vascular host response. (A) Rt2 Profiler Angiogenesis PCR
Array after 1 week of dynamic culture in vitro. Green squares represent genes expressed higher in monocultured MSCs, and red squares represent
genes expressed higher in MSC/EC constructs. Fold changes greater than three are indicated with green or red font, respectively. (B)
Corresponding VEGF of mouse origin was higher in monocultured constructs at 1 week of implantation. However, the difference was not
statistically significant. (C) No difference in expression of VEGF from implanted cells was observed at 1 week, whereas an upregulation was found
at 3 weeks. *P < 0.05; n = 6. (D) Expression of mouse CD31 was slightly higher at both time points for monocultured constructs, but the
differences were not statistically significant.
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served at 3 weeks compared with 1 week, but no differ-
ence was detected between the groups (Figure 3A, left).
The expression of human α-SMA was higher in the
MSC/EC group at 1 week of culture in vitro, and at 1
and 3 weeks in vivo (Figure 3A, right). However, the dif-
ferences were not statistically significant. Interestingly,
when compared with control scaffolds in which no cells
were implanted, a strong downregulation of mouse α-
SMA was observed for both mono- and cocultured con-
structs (Figure 3B). Positive staining for human α-SMA
was found in both groups, surrounding functional blood
vessels identified by the presence of red blood cells in
the lumen (Figure 3C). When evaluating MSCs in vitro
for expression of α-SMA, positive staining comparable
to that of SMCs was observed for cells grown in stand-
ard culture conditions, showing that undifferentiated
MSCs express α-SMA (Figure 3D). These findings sug-
gest a perivascular role for MSCs in the development of
a functional microvasculature in vivo.
The osteogenic potential was evaluated at 3 weeks
after implantation, and positive staining for ALP and
Alizarin Red was observed for both experimental groups
(Figure 4A). Gene expression of ALP was upregulated incocultured constructs when compared with both empty
controls and monocultured constructs. However, only
the former comparison was statistically significant.
Osteogenic biomarkers OP and COL I were both simi-
larly expressed in the two groups (Figure 4B). Figure 4C
shows the total area of calcification as positive Alizarin
Red staining, which was higher for both cellular con-
structs when compared with empty controls, where no
positive staining was found. Only minor differences were
observed between the two experimental groups.
Human ki67 was used as a biomarker for proliferation
of human cells, and the relative gene expression was
evaluated before in vivo implantation and at 1 and 3
weeks in vivo. Human ki67 was significantly upregulated
(P < 0.05) in the MSC/EC constructs before implantation
and at 1 week. At 3 weeks, a difference was still observed,
but was not statistically significant (Figure 5A).
After 3 weeks of subcutaneous implantation, scaffolds
from both groups exhibited penetration with normal
vascularized loose connective tissue (Figure 5B, upper).
The mesenchymal cell marker vimentin was used to
evaluate the presence of human cells in vivo, and cells
positive for human vimentin were detected in both
groups (Figure 5C, upper). Masson trichrome stain was
Table 1 Functional grouping of osteogenic gene
expression after 1 week of dynamic culture in vitro
Gene Full name Fold change
Skeletal development
AHSG Alpha-2-HS-glycoprotein −3.7044
AMBN Ameloblastin −4.9367
AMELY Amelogenin −4.68
ENAM Enamelin −2.8164
STATH Statherin −9.6485
ALPL Alkaline phosphatase −3.6727
CALCR Calcitonin receptor −2.9072
DMP1 Dentin matrix acidic phosphoprotein 1 −3.9158
BMP3 Bone morphogenetic protein 3 −4.5315
BMP5 Bone morphogenetic protein 5 −4.9367
COL2A1 Collagen type II, alpha 1 −3.373
Cell growth and differentiation
IGF1R Insulin-like growth factor 1 receptor 3.5697
IGF2 Insulin-like growth factor 2 4.9403
TGFB3 Transforming growth factor beta 3 2.2567
IGF1 Insulin-like growth factor 1 2.964
BMP2 Bone morphogenetic protein 2 2.476
GDF10 Growth differentiation factor 10 2.2778
TWIST1 Twist homolog 1 2.1232
FLT1 Fms-related tyrosine kinase 1 −8.1751
Extracellular matrix molecules
MMP10 Matrix metallopeptidase 10 −5.3112
CSF2 Colony-stimulating factor 2 −4.9367
CSF3 Colony-stimulating factor 3 −4.9367
ITGAM Integrin alpha M −3.8558
COL14A1 Collagen type XIV, alpha 1 2.7336
CTSK Cathepsin K 2.019
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was evident in cell/scaffold constructs implanted into
calvarial bone defects (Figure 5C, lower).
Discussion
This study evaluated the potential for ECs in combin-
ation with MSCs to create microvascular networks in
three-dimensional bone tissue engineered constructs. To
assess how coculture of MSCs with ECs influenced the
phenotype of cells delivered for tissue regeneration
in vivo, we studied angiogenic and osteogenic gene-
expression profiles after 1 week of dynamic culture
in vitro. The results show that formation of an endothe-
lial microvascular network resulted in upregulated ex-
pression of human ki67, a well-described biomarker for
cellular proliferation [17]. Various genes involved in cell
growth and differentiation, were upregulated in MSC/EC
constructs, and the influence of ECs on both angiogenic
and osteogenic gene-expression profiles was evident.The results of the in vivo experiment showed that the
response to the angiogenic signal on ingrowth of CD31-
positive cells was similar for both experimental groups,
but that implanted human MSCs could support functional
blood vessels as perivascular cells. Histologic evaluation
showed that generation of ectopic bone in poly(LLA-co-
DXO) scaffolds required a local osteoinductive environ-
ment. However, increased osteogenic potential was found
for both cellular constructs compared with empty con-
trols, and expression of ALP was significantly upregulated
in the presence of endothelial microvascular networks.
The potential use of biodegradable polymers as scaf-
folds for cell-based tissue regeneration was reviewed by
Gunatillake and Adhikari [18]. An important attribute of
these materials is their chemical versatility, allowing
mechanical properties and material degradation to be
tailored to specific clinical conditions. Hence these ma-
terials are potentially applicable to regeneration of vari-
ous types of tissue. The response of both OBs and MSCs
to the scaffold used in this report has been investigated
in several in vitro studies [13,15,19]. The results from
these studies suggest that the material enhances osteo-
genic differentiation of both cell types. Our results show
that the osteogenic stimulatory effects of the scaffold
material and the cellular interactions are not sufficient
to induce ectopic bone formation in NOD/SCID-mice.
However, several other authors have used polymer
scaffolds to deliver osteogenic growth factors and then
induce ectopic bone formation [20,21]. MSC/polymer
constructs, cultured with or without osteogenic stimula-
tory conditions before implantation, have also been in-
vestigated for their osteogenic potential, with successful
generation of ectopic bone [8,22].
Complex tissues depend on functional blood vessels
for cell survival as well as for tissue organization after
in vivo implantation. Prevascularization, in which endo-
thelial cell microvascular networks are developed
in vitro, have been attempted with different cells and
materials. Microvascular networks were created by
using MSC/EC coculture spheroids, in which limited
functionality was found in vivo [23]. Asakawa et al. [24]
were able to generate a three-dimensional tissue by
using dermal fibroblasts as supporting cells for develop-
ing endothelial microvascular networks, whereas Yu
et al. [25] seeded ECs with OBs in poly-ε-caprolactone
and hydroxyapatite scaffolds, and subsequently demon-
strated enhanced osteogenesis in rat long-bone defects.
Thus, for development of a de novo microvasculature,
ECs depend on supporting cells, a role that can be
undertaken by several cell types [26,27]. Our results
show that a poly(LLA-co-DXO) scaffold can support the
formation of EC/MSC microvascular networks in three
dimensions, suggesting that prevascularized tissue re-
generation with this material is feasible.
Figure 3 Expression of perivascular α-smooth muscle actin of mouse and human origin. (A) Left: Expression of mouse α-SMA was
upregulated at 3 weeks in vivo compared with 1 week. However, intergroup differences were not found. Right: Expression of human α-SMA was
upregulated in coculture in vitro and at both time points in vivo, although the differences were not statistically significant. (B) The expression of
α-SMA was strongly downregulated for both cell/scaffold constructs at 3 weeks when compared with empty control scaffolds. ***P < 0.001;
n = 6. (C) Positive staining for human α-SMA (20×) surrounding functional blood vessels was observed in both experimental groups at 3 weeks.
Scale bar = 100 μm. (D) In vitro evaluation of MSCs showed positive α-SMA staining comparable to SMC (20×). Scale bar = 100 μm.
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before in vivo implantation and found altered gene-
expression profiles with reference to both angiogenesis
and osteogenesis. Genes related to skeletal development
and the ECM were highly expressed in monocultured
MSCs. These results are in agreement with an earlier
study by Fuchs et al. [28], showing that the expression
of osteogenic markers from OBs was downregulated in
the presence of ECs in 4-week cultures. Long-term
incubation in vitro is beneficial when studying the
mineralization process, but might be considered less
practical for clinical applications and have less potential
for regenerating bone [29]. Although an overview of
osteogenic and angiogenic gene-expression profiles were
generated in the present work, functional evaluations of
candidate targets might have been of interest to assess
further the effect from regulation of individual genes.
Evaluations on tissue development were made on the
gene, protein, and morphologic level, to determine the
effect of the paracrine signal from all biologic factors de-
livered by the tissue-engineered constructs.
Murine models of ectopic bone formation are widely
used to evaluate osteogenic potential in bone-tissue en-
gineering. By using a subcutaneous mouse model to
compare implantation of MSCs and OBs, Tortellini et al.
[30] reported that MSCs enhanced vascularizationthrough increased recruitment of host ECs. MSCs are
known to secrete multiple paracrine factors stimulating
EC migration and wound healing [31], and this might be
downregulated when ECs are already present in the con-
struct. In the present study, angiogenic gene expression
was higher in monocultured MSCs at the moment of im-
plantation, suggesting that increased angiogenic stimula-
tion could be delivered to the host bed from MSCs alone.
With ECs already present, paracrine signals to attract and
activate ECs might be less relevant in the coculture system.
An initial response from the host circulation was also
found as higher expression of mouse VEGF at 1 week,
when compared with cocultured constructs. The oppos-
ite regulation of human VEGF was observed, with
upregulation in the coculture group at the end of the ex-
perimental period. These findings might be interpreted
as cell/scaffold constructs containing ECs having a
stronger ability to maintain a proangiogenic signal after
implantation. However, the expression of mouse CD31
was not notably different for the two experimental
groups, suggesting a similar vascular host response with
regard to the presence of ECs. The total number of
blood vessels was not quantified, but no obvious differ-
ence could be observed.
Recruitment of perivascular cells with subsequent pro-
duction of basement membrane proteins are key events
Figure 4 Osteogenic potential of tissue-engineered constructs after 3 weeks of subcutaneous implantation. (A) Positive staining for
alkaline phosphatase (purple) could be observed for both cell/scaffold constructs, as shown at 10× and 60× magnification. Scale bar: upper = 100
μm, lower = 20 μm. Calcified nodules were observed as positive Alizarin Red staining (red) shown at 4× and 40× magnification. Scale bar:
upper = 100 μm, lower = 20 μm. (B) Gene-expression levels of osteogenic biomarkers alkaline phosphatase (ALP), osteopontin (OP), and collagen
I (COL I) were evaluated with real-time RT-PCR, and increased expression of ALP was detected for MSC/EC constructs compared with empty
controls. **P < 0.01; n = 6. (C) Quantification of Alizarin Red staining did not reveal significant differences between MSC and MSC/EC constructs.
No positive staining was observed in the control scaffolds without cells; n = 4.
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SMA originated from mouse cells was similarly ex-
pressed on the mRNA level in MSC and MSC/EC con-
structs, with an expected increase for both groups
between 1 and 3 weeks, as scaffolds were increasinglyFigure 5 Survival of implanted cells and the effect of local tissue sign
upregulated at the moment of implantation after 1 week of culture in vitro
longer significant; n = 6. (B) Upper: Representative light micrographs (HE st
tissue at 3 weeks subcutaneous implantation (20×). Lower: Masson trichrom
EC constructs at 3 weeks in vivo. (C) Upper: Representative fluorescent micr
at 3 weeks in vivo (20×). Lower: Positive control of MSC/EC implanted in a
Scale bars = 100 μm.penetrated with tissue. MSCs in cell/scaffold constructs
responded to the presence of ECs by upregulating the
expression of α-SMA at all time points, although the
differences were not statistically significant. In vitro
evaluation showed that α-SMA was expressed also inaling on osteogenesis. (A) Expression of human ki67 was
, as well as at 1 week in vivo. At 3 weeks in vivo, the difference was no
aining) of scaffolds penetrated with normal vascular loose connective
e staining (20×) could not detect osteoid formation in MSC or MSC/
ograph from the coculture group of cells positive for human vimentin
rat calvarial bone defect showing osteoid formation at 8 weeks (20×).
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in vivo experiment showed that adding ECs resulted in
further upregulation of α-SMA. However, the ability of
MSCs to function as perivascular cells for developing
vessels did not depend on the coimplantation of ECs.
Gene expression of α-SMA was strongly downregulated
for both constructs when compared with empty con-
trols, suggesting less demand for transcription of α-SMA
after implantation of MSCs. Furthermore, α-SMA-posi-
tive cells surrounding functional blood vessels were
found well distributed in the connective tissue for both
experimental groups. In addition to α-SMA, positive
staining of human vimentin was demonstrated, showing
that implanted MSCs were a viable part of the connect-
ive tissue.
Kaigler et al. [8] studied dermal microvascular endo-
thelial cells and MSCs seeded on poly(lactic co-glycolic
acid) scaffolds implanted subcutaneously in immunode-
ficient mice. No significant difference was observed in
the number of total blood vessels at 2 and 4 weeks, but
in line with our findings, a higher percentage of human-
derived vessels were found in MSC/EC constructs. At 4
weeks, the area of bone as a percentage of the total tis-
sue area was as high as 35% in the MSC/EC group. In
the present study, we cultured cells for 1 week before
implantation in vivo for 3 weeks, but no osteoid forma-
tion was detectable within the constructs. We used
MSCs at a lower passage, and this might have influenced
the differentiation stage of cells at implantation and,
subsequently, the osteogenic potential. In addition, the
difference in density of cells with regenerative potential
should be considered in the interpretation of the results.
When evaluating the expression of osteogenic bio-
markers, we found an upregulation of ALP for MSC/EC-
constructs compared with both monocultured MSCs
and empty control scaffolds. These results are in accor-
dance with those of Xue et al. [9] with a two-dimensional
coculture MSC/EC model. Compared with monocultured
MSCs, at 5 days, multiple osteogenic genes from the
cocultured MSC/EC exhibited downregulation, with the
exception of ALP [9]. The proposed mechanism for endo-
thelial influence on osteogenic differentiation was there-
fore that ECs promoted maintenance of MSCs at a
proliferative stage rather than inducing terminal differenti-
ation. Although full penetration of tissue within scaffolds
was confirmed at the end of the experiment in the present
work, longer observation periods might have been of
interest to follow further the remodeling and maturation
of the tissue.
Positive Alizarin Red staining was found in both cell/
scaffold constructs, but not in scaffolds implanted with-
out cells. The majority of the area within the material
was filled with connective tissue, with interspersed calci-
fied nodules. The total area of positive staining was notsignificantly different for the two experimental groups.
Both MSCs and MSC/EC thus enhanced the osteogenic
potential of poly(LLA-co-DXO) scaffolds after ectopic
implantation.
Conclusions
The results demonstrate that by using a construct com-
prising MSCs and ECs seeded onto poly(LLA-co-DXO)
scaffolds, we can create three-dimensional microvascular
networks in vitro and sustain them in vivo. Furthermore,
human MSCs can serve as perivascular cells in the de-
velopment of functional blood vessels, independent of
implanted ECs. The presence of endothelial microvascu-
lar networks leads to altered angiogenic and osteogenic
gene expression on implantation, and seeding of MSCs
with or without ECs increases the osteogenic potential
of tissue-engineered constructs.
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